Check Claims Before You Publish

Key quantitative profile

• Total works: ~26–29 (conflicting sources; Semantic Scholar / supplied list vs OpenAlex) — OpenAlex reports 29 works and 960 citations with h-index 17, while internal dataset reports 26 papers, 858 citations and h-index 16 (OpenAlex author record).
• High-impact single papers: Science (1989 msDNA in E. coli; cited ~140) and Cell (1987 msDNA structure; cited ~90) indicate peak influence in late 1980s (1989 Science msDNA, 1987 Cell msDNA).

Scientific contributions & thematic strengths

1. msDNA/retron biology and bacterial reverse transcriptases: Lampson is a primary contributor to discovery/characterization of msDNA and retron-encoded reverse transcriptases, combining biochemical mapping, sequencing, and functional characterization (msDNA structure Cell 1987).
2. Extension to clinical isolates and enzymology: Work demonstrating msDNA in clinical E. coli and purifying reverse transcriptase complexes indicates biological breadth beyond model myxobacteria and contributes enzymatic evidence (1989 Science msDNA in E. coli).
3. Antibiotic-resistance plasmids and clinical microbiology: Early work on Staphylococcus epidermidis plasmids (pNE131/pNE24) and MLS resistance maps sequences and mechanisms of macrolide-lincosamide-streptogramin B resistance (1986 pNE131 plasmid sequence).

Evaluation of scientific strength (evidence-based)

What the data support:

• High methodological competence in classical molecular microbiology and biochemistry (pulse-chase, mapping, Maxam-Gilbert sequencing, purification of RT complexes) as seen in Cell/Science/J Bacteriol papers — experimental depth and multiple complementary assays increase confidence in conclusions (msDNA mapping methods).
• Influence concentrated historically (late 1980s–mid 1990s); citation profile shows few high-impact discoveries rather than a broad, recent body of high-volume work (OpenAlex counts_by_year).

Limitations, blindspots, and risks of over-interpretation

• Temporal concentration: Most highly-cited work dates to the 1980s–1990s; lack of many recent high-impact publications reduces evidence of continuing leadership or sustained methodological updating.
• Generality: Early msDNA mechanistic models were proposed from gel/sequencing-era techniques; while robust then, modern genomics/structural methods (deep sequencing, cryo-EM) could refine or revise mechanistic details — absence of such follow-up limits contemporary interpretability (2005 retron review).
• Metrics variance: different sources give slightly different counts (26 vs 29 papers; 858 vs 960 citations; h-index 16 vs 17) — small discrepancies typical of bibliographic aggregators but should be noted when citing metrics (OpenAlex vs local metrics).

Practical takeaways for a reader or evaluator

1. If you need authoritative biochemical mapping/characterization of bacterial msDNA/retrons, Lampson's Cell and Science manuscripts are primary sources and methodologically strong (Primary structural msDNA).
2. For modern functional genomics or retron engineering questions, integrate Lampson's foundational work with recent retron/genomic studies (post-2010) because mechanisms and functions have been further explored using high-throughput methods (not covered extensively in Lampson's core era).

References (selected primary works)

• 1987 Cell msDNA structure
• 1989 Science msDNA in E. coli
• 1986 pNE131 plasmid sequence
• 2005 retron review